mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.2 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.2 |
mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.2 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.2 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |